Veno-venous extracorporeal membrane oxygenation use in the treatment of bleomycin pulmonary toxicity

Aakash Shah, Chetan Pasrija, Anthony Kronfli, Brody Wehman, Bartley P. Griffith, Pablo G. Sanchez, Jose P. Garcia, Zachary N. Kon

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Pulmonary toxicity is a devastating complication of bleomycin chemotherapy. This insult is likely exacerbated by the free radical injury induced by high inspired oxygen content, which is required to support these patients. Traditional treatment consists of high-dose corticosteroids. We report the case of a 45-year-old man who developed bleomycin pulmonary toxicity, which failed to respond to treatment with highdose corticosteroids. We used protectivemechanical ventilatory settings while supported on veno-venous extracorporeal membrane oxygenation using a bicaval dual-lumen, single cannula systemto allow for lung recovery. This case demonstrates the feasibility of using veno-venous extracorporeal membrane oxygenation to treat bleomycin pulmonary toxicity in a patient who has failed traditional therapy.

Original languageEnglish
Pages (from-to)144-146
Number of pages3
JournalInnovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
Volume12
Issue number2
DOIs
StatePublished - 2017

Keywords

  • Acute respiratory distress syndrome
  • Bleomycin toxicity
  • Extracorporeal membrane oxygenation

Fingerprint

Dive into the research topics of 'Veno-venous extracorporeal membrane oxygenation use in the treatment of bleomycin pulmonary toxicity'. Together they form a unique fingerprint.

Cite this